June 3, 2026
A precision drug delivery technology with roots at UNC-Chapel Hill has launched a first-in-human phase I clinical trial of its iontophoretic oncology platform (IOP) for pancreatic cancer, now open for enrollment.
May 26, 2026
UNC Lineberger's Justin Milner, PhD, has emerged in recent years as a young scientist to watch in the field of cancer immunology.
May 7, 2026
Channing J. Der, PhD, and Jen Jen Yeh, MD, published an editorial contextualizing a landmark clinical study evaluating daraxonrasib, a first-in-class drug targeting KRAS-mutant metastatic pancreatic ductal adenocarcinoma (PDAC).
March 19, 2026
Justin Milner, PhD, has received a grant from the V Foundation to support his research using CAR-T immunotherapy as treatment for pancreatic cancer, one of the most lethal types of cancer.
March 11, 2026
Kirsten Bryant, PhD, has been awarded a $100,000 seed grant for her project that seeks to define and target metabolic changes associated with RAS inhibition in pancreatic ductal adenocarcinoma.
February 24, 2026
A new generation of investigators is tackling one of oncology's most persistent puzzles. Three of these young scientists discuss the rewards and challenges of committing their futures to this field in an era defined by encouraging scientific and technological progress but also financial uncertainty.
February 17, 2026
In a collaboration between several labs at UNC Lineberger, researchers have defined cancer-associated fibroblast (CAF) subtypes that are clinically robust, prognostic, and predictive of immunotherapy response and developed a clinical classifier designed to distinguish between these subtypes in patients.
July 16, 2025
The SToP Cancer SPORE grant's Career Enhancement Program supports a diverse group of young researchers seeking to gain key insight into critical areas of pancreatic cancer research. Here are highlights from the program's first two projects.
May 21, 2025
The Selective Targeting of Pancreatic Cancer (SToP) Specialized Program of Research Excellence (SPORE) grant has teamed up with UNC Lineberger's Developmental Research Program (DRP) to support novel projects seeking to gain key insight into critical areas of pancreatic cancer research.
April 25, 2025
UNC Lineberger researchers and colleagues have discovered an important overlap in genes regulated by the activity of three proteins that support the growth of pancreatic cancer.